Yorkshire Cancer Research Bowel Cancer Improvement Program
Research type
Research Study
Full title
Does intensive multidisciplinary team intervention improve bowel cancer outcomes in Yorkshire. The Yorkshire Cancer Research Bowel Cancer Improvement Programme (YCR BCIP)
IRAS ID
227673
Contact name
Philip Quirke
Contact email
Sponsor organisation
University of Leeds
Duration of Study in the UK
3 years, 5 months, 31 days
Research summary
There is evidence of variation in the management of bowel cancer and outcomes for patients across Yorkshire and the Humber. This study aims to understand the variation and then improve outcomes by addressing these issues.
The study will use routine datasets collected during the diagnosis and management of patients with bowel cancer in the NHS. These datasets are already received by the National Cancer Registration and Analysis Service (NCRAS). NCRAS have linked these datasets together to provide an integrated dataset and we have analysed this to provide basic information about bowel cancer care. We now wish to enhance these data further through linkage to new existing datasets and from data we collect. This will generate high quality intelligence about the management of patients with bowel cancer across Yorkshire and Humber.
Additional data will be collected from patients from participating Trusts across the region. Patients with bowel cancer being treated in participating hospitals will be asked to consent to participate in the collection of patient reported outcome measures (PROMS) via patient questionnaires. Patients will also be consented for the use of some of their tissue, which is excess to that required for diagnosis and treatment, to be sent to the research team for additional novel biomarker testing. The data from the PROMS and the tissue will be linked to the rest of the integrated dataset in a secure environment within NCRAS. The study team will use the intelligence to identify areas that could be improved and develop educational programmes to address them, and subsequently assess the impact of these on the outcomes of bowel cancer patients in Yorkshire and Humber. The updated data will provide information about the services at the start of the programme and then enable the study team to analyse changes in outcomes across the years.REC name
West Midlands - Solihull Research Ethics Committee
REC reference
17/WM/0374
Date of REC Opinion
12 Dec 2017
REC opinion
Further Information Favourable Opinion